Lipids, cholesterols, statins and liver cancer: a Mendelian randomization study
AimTo investigate the causal relationship of serum lipid indicators and lipid-lowering drugs with the risk of liver cancer using Mendelian randomization study.MethodsA two-sample Mendelian randomization (TSMR) study was performed to investigate the causal relationship between serum levels of lipid i...
Main Authors: | Zicheng Liang, Zhen Zhang, Xiaoning Tan, Puhua Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1251873/full |
Similar Items
-
Predicting the effect of statins on cancer risk using genetic variants from a Mendelian randomization study in the UK Biobank
by: Paul Carter, et al.
Published: (2020-10-01) -
Effect of blood lipids and lipid-lowering therapies on osteoarthritis risk: A Mendelian randomization study
by: Zhaolun Wang, et al.
Published: (2022-11-01) -
Mendelian Randomization Analysis Reveals Statins Potentially Increase Amyotrophic Lateral Sclerosis Risk Independent of Peripheral Cholesterol-Lowering Effects
by: Wenjing Wang, et al.
Published: (2023-05-01) -
Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study
by: Chengming Chen, et al.
Published: (2024-03-01) -
Lipid-lowering drug targets and lung related diseases: a Mendelian randomization study
by: Haifeng Yu, et al.
Published: (2024-12-01)